Ensign Group/$ENSG
1D1W1MYTD1Y5YMAX
Capital at risk
About Ensign Group
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
- Ticker
- $ENSG
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 46,000
- Headquarters
- San Juan Capistrano, United States
- Website
- ensigngroup.net
Ensign Group Metrics
BasicAdvanced
$9.9B
26.93
$6.38
0.69
$0.26
0.15%
Price and volume
Market cap
$9.9B
Beta
0.69
52-week high
$218.00
52-week low
$141.58
Average daily volume
346K
Dividend rate
$0.26
Financial strength
Current ratio
1.211
Quick ratio
1.119
Long term debt to equity
0.869
Total debt to equity
0.92
Dividend payout ratio (TTM)
3.91%
Interest coverage (TTM)
60.21%
Profitability
EBITDA (TTM)
582.735
Gross margin (TTM)
16.57%
Net profit margin (TTM)
6.90%
Operating margin (TTM)
8.55%
Effective tax rate (TTM)
24.03%
Revenue per employee (TTM)
$120,000
Management effectiveness
Return on assets (TTM)
5.49%
Return on equity (TTM)
16.97%
Valuation
Price to earnings (TTM)
26.926
Price to revenue (TTM)
1.806
Price to book
4.07
Price to tangible book (TTM)
4.25
Price to free cash flow (TTM)
23.64
Free cash flow yield (TTM)
4.23%
Free cash flow per share (TTM)
7.266
Dividend yield (TTM)
0.15%
Forward dividend yield
0.15%
Growth
Revenue change (TTM)
18.89%
Earnings per share change (TTM)
15.60%
3-year revenue growth (CAGR)
17.44%
10-year revenue growth (CAGR)
13.71%
3-year earnings per share growth (CAGR)
14.77%
10-year earnings per share growth (CAGR)
21.61%
3-year dividend per share growth (CAGR)
4.22%
10-year dividend per share growth (CAGR)
5.04%
What the Analysts think about Ensign Group
Analyst ratings (Buy, Hold, Sell) for Ensign Group stock.
Analyst projections of the future price of Ensign Group stock.
Bulls say / Bears say
Second-quarter revenue rose 17.3% and adjusted EPS rose 20.8% year on year, while same-facility occupancy reached 84.1% and skilled-mix revenue increased 10.1%. Ensign raised its 2026 EPS guidance to $7.75-$7.85, signalling continued operating momentum. (The Ensign Group)
Ensign added 20 operations in and after the second quarter and says it has a continuing pipeline of turnaround opportunities. More than $850 million of cash and unused credit capacity gives it room to fund acquisitions without an immediate need for fresh equity. (Skilled Nursing News, The Ensign Group)
Standard Bearer adds a recurring property-income stream alongside the operating business: it owned 177 properties, generated $44.1 million of quarterly rent and $24.7 million of FFO, and had 38 properties leased to third-party operators. Its triple-net leases can diversify cash flow and support further expansion. (The Ensign Group)
Muddy Waters alleges that Ensign used nominal or off-site nursing-home administrators at a number of facilities, potentially undermining licensing and Medicare and Medicaid compliance. If regulators substantiate the claims, the company could face costly remediation, sanctions and damage to its acquisition model. (Muddy Waters Research)
Hunterbrook alleges that Ensign’s historical staffing levels were materially below the care implied by patient acuity, and estimates that bringing staffing up would impose a large recurring cost. The claims rely partly on older data, but any regulatory or operational response could put pressure on margins and reputation. (Hunterbrook Media)
The newest Texas acquisitions have low occupancy and limited skilled mix and are not expected to add profit in the near term. At the same time, second-quarter expenses rose 17.3% and revenue missed analysts’ estimates, highlighting the integration and cost risk behind acquisition-led growth. (Skilled Nursing News, Yahoo Finance)
Data summarised monthly by Lightyear AI. Last updated on 23 Sept 2026.
Ensign Group Financial Performance
Revenues and expenses
Ensign Group Earnings Performance
Company profitability
Upcoming events
Ensign Group News
AllArticlesVideos
Kaplan Fox is Investigating Claims Against The Ensign Group, Inc. (ENSG) on Behalf of Investors
Newsfile Corp1 day ago
Kaplan Fox Encourages The Ensign Group, Inc. (ENSG) Investors Who Suffered Losses to Learn About Their Legal Rights
Newsfile Corp3 days ago
Kaplan Fox Investor Alert: The Ensign Group, Inc. (ENSG) Investigated for Possible Securities Law Violations
Newsfile Corp5 days ago
Funds containing Ensign Group
AllEURUSDGBP
Fund name | Fund size | $ENSG weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.54% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.29% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.29% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.15% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.15% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.